MYC and EGR1 synergize to trigger tumor cell death by controlling NOXA and BIM transcription upon treatment with the proteasome inhibitor bortezomib
Matthias Wirth(German Cancer Research Center), Günter Schneider(TUM Klinikum)
Cited by 64
Related Papers
IKKα controls p52/RelB at the skp2 gene promoter to regulate G1‐ to S‐phase progression
|The EMBO Journal|2006|91
HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells
|Molecular Cancer|2010|80
Casein kinase II inhibition induces apoptosis in pancreatic cancer cells
|Oncology Reports|2007|40
Targeting the ubiquitin‐proteasome system in a pancreatic cancer subtype with hyperactive MYC
|Molecular Oncology|2020|23